Antituberculous therapy in pregnancy. Risks to the fetus.
West J Med
; 127(3): 195-8, 1977 Sep.
Article
en En
| MEDLINE
| ID: mdl-906455
A total of 1,939 reported births to mothers who received isoniazid ethambutol, rifampin and streptomycin alone or in combination, for all or part of their pregnancies, were surveyed to determine teratogenicity of these agents. There was no significant increase in birth defects with isoniazid, ethambutol and rifampin, in contrast to the use of streptomycin which was associated with mild auditory and vestibular defects. Guidelines for the treatment of active tuberculosis in pregnancy are therefore established.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Complicaciones Infecciosas del Embarazo
/
Tuberculosis Pulmonar
Tipo de estudio:
Etiology_studies
/
Guideline
/
Qualitative_research
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
West J Med
Año:
1977
Tipo del documento:
Article
Pais de publicación:
Estados Unidos